Your browser doesn't support javascript.
Chronic spontaneous urticaria exacerbation in a patient with COVID-19: rapid and excellent response to omalizumab.
Criado, Paulo R; Criado, Roberta F J; Pincelli, Thais P; Yoshimoto, Thais A; Naufal, Gabriela G A; Abdalla, Beatrice M Z.
  • Criado PR; Dermatology Department, Centro Universitário Saúde ABC (Faculdade de Medicina do ABC), An UCARE Center, Santo André, Brazil.
  • Criado RFJ; Alergoskin Alergia e Dermatologia, An UCARE Center, Santo André, Brazil.
  • Pincelli TP; Dermatology Department, Centro Universitário Saúde ABC (Faculdade de Medicina do ABC), An UCARE Center, Santo André, Brazil.
  • Yoshimoto TA; Alergoskin Alergia e Dermatologia, An UCARE Center, Santo André, Brazil.
  • Naufal GGA; Dermatology Department, Mayo Clinic Jacksonville, Florida, USA.
  • Abdalla BMZ; Dermatology Department, Centro Universitário Saúde ABC (Faculdade de Medicina do ABC), An UCARE Center, Santo André, Brazil.
Int J Dermatol ; 59(10): 1294-1295, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-721133

Full text: Available Collection: International databases Database: MEDLINE Main subject: Anti-Allergic Agents / Symptom Flare Up / Omalizumab / Chronic Urticaria / COVID-19 Type of study: Case report / Diagnostic study / Prognostic study Topics: Long Covid Limits: Female / Humans / Middle aged Language: English Journal: Int J Dermatol Year: 2020 Document Type: Article Affiliation country: Ijd.15134

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Anti-Allergic Agents / Symptom Flare Up / Omalizumab / Chronic Urticaria / COVID-19 Type of study: Case report / Diagnostic study / Prognostic study Topics: Long Covid Limits: Female / Humans / Middle aged Language: English Journal: Int J Dermatol Year: 2020 Document Type: Article Affiliation country: Ijd.15134